跳至主要内容
临床试验/IRCT20200127046282N41
IRCT20200127046282N41招募中1 期

Investigating the safety and efficacy of Wharton jelly mesenchymal stem cells secretome injection in female androgenetic alopecia (Clinical, Biometric and Histopathological evaluation)

Tehran University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 45 years(—)
性别
Female

入选标准

  • patients with female androgenetic alopecia grade 5
  • Patients aged 30 to 45 years
  • Hormonally healthy patients

排除标准

  • Presence of evidence of sepsis, immunosuppression and cancer
  • Use of oral drug treatment for androgenic hair loss (such as finasteride, dutasteride or any other anti-androgen drug) in 12 months the past
  • Use of local drug treatment of androgenic hair loss (such as minoxidil, prostaglandin analogues, retinoids orCorticosteroids) in the last 12 months
  • Discovering another cause for the patient's hair loss
  • Non-cooperation of the patient until the end of the study

研究者

相似试验